Ninth bottle shop proposed for Swan Hill as councils lose veto power
Victorian councils want to retain their power of veto over new liquor outlets in country towns, amid fierce debate about the links between family violence and access to alcohol.
In Swan Hill, a northern Victorian town ranked fifth in the state for family violence, mother and foster carer Bec Wolfe-Charles is among those objecting to a proposed new bottle shop.
She wants more play spaces in her neighbourhood where she can spend time with her daughter, Eloise, rather than another liquor store in a town that already has eight.
But she worries the decision to approve the bottle shop is being taken out of local hands.
From July 1, Liquor Control Victoria will take responsibility for liquor licence decisions, stripping local councils of the right to refuse planning permits.
Swan Hill's local government area has a population of 21,000.
The I Can Smell A Dead Duck company has applied for planning permission to open a ninth liquor outlet in the town, a bottle shop in a former furniture store.
A spokesperson for the Department of Justice and Community Safety said there was no cap on the number of liquor licences allowed in one town and that Swan Hill residents will still have the opportunity to object to the application when Liquor Control Victoria puts it on public notice.
Swan Hill Rural City Council Mayor Stuart King said councils should have more, rather than less, control over new liquor store applications and is concerned that city-based bureaucrats will not properly understand what the town needs.
The owners of I Can Smell A Dead Duck have been contacted for comment.
Women's Health Loddon Mallee chief executive officer Kellie Dunn said communities like Swan Hill were right to push back.
"If they are voicing that it is not right for them and that they feel that there is a saturation [of alcohol outlets], the government really needs to listen to them as part of the planning process," Ms Dunn said.
An independent review into a Dan Murphy's store in Darwin in 2021 heard that the chain liquor store's operator, Endeavour Group, disputed the link between new bottle shops and more violence.
But public health researchers say the link is clear.
Data from the addiction treatment centre Turning Point showed that since 2018, paramedics had been called to about two alcohol-related incidents per week in Swan Hill, and alcohol was the most common drug found in intimate partner violence.
"The more alcohol that is around a community, or the higher the availability, the more domestic violence and other harms occur in that community," strategic lead Rowan Ogeil said.
Dr Ogeil said victim-survivors from socio-economic disadvantaged areas like Swan Hill were three-and-a-half times more likely to have an ambulance respond to interpersonal violence involving alcohol or drugs.
In 2015, the Royal Commission into Family Violence recommended that liquor licensing rules consider the role of alcohol in family violence.
In a statement, a spokesperson for the Department of Community Justice and Safety said Liquor Control Victoria already considered social harms.
If you need help immediately call emergency services on triple-0
A fortnight out from the change, the head of the Municipal Association of Victoria said there was no clarity on how "this major impact" would affect local government.
"We will no longer be the people that determine whether the planning application is appropriate or not," MAV president Jennifer Anderson said.
"A lot of councils may not be aware of the legislation.
"But certainly, for those that are aware, like Swan Hill for example, it is a great concern because certain areas are known to have problems with alcohol, and so there may be areas where they have the knowledge to know this [application] is not appropriate."
Cr Anderson said the MAV and its member councils had little knowledge of the new process under Liquor Control Victoria and the Department of Planning, other than that local councils could make a submission to Liquor Control Victoria if they wanted to.
The Department of Planning has not provided a formal response to the ABC's queries.
Additionally, liquor store applications that have a floor space of at least 750 square metres trigger a community impact assessment, the spokesperson said.
The assessment measures the application against the area's social harms, such as the family violence rate, or the proximity to schools.
At 628sqm, the proposed Swan Hill bottle shop does not need a formal harm assessment to be done.
The harm assessment process was tested last year when the Victorian Liquor Commission backed Hepburn Shire Council's decision to deny an application by Endeavour Group to place a Dan Murphy's bottle shop near a school.
Endeavour Group is contesting the decision at the Victorian Civil and Administrative Tribunal.
Swan Hill independent bottle shop owner John Charleson said the assessment criteria did not work if a town comprises one main street because a 500-metre radius was applied.
"So, the square metreage of a circle basically, a 500-metre radius in our town, really should be put into context and be taken in a long rectangular view."
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News.com.au
2 hours ago
- News.com.au
Health Check: A pancreatic cancer ‘cure' has been elusive, but Amplia may have cracked the nut
Amplia shares soar almost 50% on news of a 'complete response' in a patient with metastasised pancreatic cancer Syntara and Kazia also report progress with their cancer drug candidates Emvision pockets $5 million of non-dilutive grant funding Has Amplia (ASX:ATX) cured pancreatic cancer, one of the deadliest tumour types? The drug developer reports a 'pathological complete response' in an advanced (metastatic) pancreatic cancer patient – an 'extremely rare' event. A pathological complete response means there are no signs of cancer in tissue examined by a pathologist following surgical removal. The treatment appeared to have reduced the tumour to a size where both the primary tumour in the pancreas and secondary liver tumours could be excised. Amplia's drug candidate AMP-945 (narmafotinib) is a focus kinase (FAK) inhibitor. FAKs are not cuss words but a type of protein overexpressed in pancreatic cancers. Dubbed Accent, Amplia's trial uses narmafotinib in combination with standard chemotherapy gemcitabine. The company is carrying out the phase 1b/2a trial at seven local sites and five in South Korea. The first stanza (1b) already has assessed dosing safety and tolerability The company notes about 5% of patients with non-metastatic pancreatic cancer achieve a pathological compete response. The bar for cancers that have spread is much higher. 'This is wonderful news for the patient and the clinical team involved,' Amplia CEO Dr Chris Burns says. 'We firmly believe this outcome further demonstrates the promising activity narmafotinib, on top of standard-of-care, is showing in treating advanced pancreatic cancer.' While one swallow doesn't make a summer, investors pushed Amplia shares as much as 47% higher before profit takers moved in. Syntara's blood cancer program looks the goods Amplia chief Chris Burns co-developed the myelofibrosis (blood cancer) drug Ojjaara, one of the few home-grown remedies to be approved by the US Food and Drud Administration (FDA). Can Syntara (ASX:SNT) follow suit? The company reports further data from its phase II trial, evaluating its drug candidate SNT-5505 in combo with the standard-of-care drug ruxolitinib. The patients had been treated with ruxolitinib for at least three years, so had enhanced symptoms such as enlarged spleen size and blood counts 'indicative of high disease burden.' The results showed eight of eleven evaluable patients (73%) achieved a reduction of more than 50% at 24 weeks. This was measured by a standard gauge called TSS50. The patients achieved a median improvement of 39%. Four out of nine patients (44%) had a spleen volume reduction of 25% at week 24 or beyond. The ongoing trial enrolled 16 patients with intermediate or high-risk myelofibrosis, for 52 weeks of treatment. However, five dropped out by the 24-week mark, a 'withdrawal rate consistent with that seen in other myelofibrsis studies of patients with similar disease severity." Eight patients reaching 38 weeks showed an average 56% reduction in symptoms. Of these, Five patients reaching 52 weeks showed a 63% decline. The company plans to release the final study results after the September quarter, when the remaining three patients have completed their treatment. Syntara intends to meet with the FDA in the September quarter to discuss the design of a pivotal phase 2c/3 study. The company announced the results on Friday and aired them at the weekend's European Hematology Association conference in Milan. Kazia's cancer news from the Nasdaq Further afield, the Nasdaq listed and formerly ASX-domiciled Kazia last week said its immunotherapy candidate paxalisib showed 'anti-tumour activity in advanced breast cancer'. In collaboration with the Queensland Institute of Medical Research (QIMR) Berghofer, Kazia is carrying out a 24-patient, phase Ib trial in combo with the standard-of-care pembrolizumab (Keytruda). The Sydney-based Kazia licensed the tech from the QIMR. The company said the data provided 'strong scientific and translational rationale for continued development of paxalisib as part of immunotherapy-based regimens.' The dual-listed Kazia delisted from the ASX last November, to reduce costs. The experience of ASX biotechs joining the Nasdaq has been patchy, to put it mildly. But Kazia shares last week more than doubled on the news. The pain of Mayne stays mainly on display Mayne Pharma (ASX:MYX) will forge ahead with a planned shareholder meeting to approve its takeover scheme of arrangement, despite receiving a second 'dear John' letter from suitor Cosette. Mayne says the correspondence – almost certainly not written on rose-scented parchment – affirms that Cosette intends to terminate the scheme implementation deed (SID) on the grounds of alleged breaches. It maintains Cosette has 'no lawful basis' to terminate the SID. So, as it stands Mayne shareholders will file into Melbourne's Intercontinental Hotel on Wednesday to vote on an offer that a reluctant suitor has no intention of executing. With no whiff of rapprochement, this one is headed for the courts. Emvision wins $5 million government grant There's no better funding than the non-dilutive variety, as EMvision Medical Devices (ASX:EMV) attests. The feds have awarded Emvision a $5 million federal government grant, to further the development of its First Responder portable brain scanner. The funds are by way of an Australian Government Industry Growth Program (IGP) Commercialisation and Growth Grant. First Responder distinguishes between bleed and clot strokes at the scene and is designed to be used by ambulances and by paramedics. The device should shorten diagnosis time – a crucial element in the patient getting the right treatment. 'First Responder … is a genuine world first product with potential to transform the landscape of pre-hospital stroke and traumatic brain injury care,' Emvision chief Scott Kirkland says. '… quite simply, if we can help save time, we can help save lives and reduce disability.' As of the end of March, Emvision had $12.5 million of cash and expected $800,000 of funding from the Australian Stroke Alliance this financial year. Heramed in maternity monitoring collab Still on non-dilutive funding, foetal monitoring device developer HeraMED (ASX:HMD) has partnered with RMIT University (RMIT) and the Digital Health Cooperative Research Centre in a research partnership. The $1.245 million project will delve into better ways to deliver maternity care for culturally and linguistically diverse women. As is the way in the modern world, the project involves refining AI-based predictive health models and tools. This is based on monitoring and collecting data on 200 pregnant women. 'The initiative will use a combination of clinical, biometric, lifestyle and genetic data, with a focus on diversity, inclusion, and clinical applicability," Heramed says. Heramed is contributing $250,000 over the 18-month project and the other parties are contributing the rest via grant funding. 'With 51% of Australians having at least one parent born overseas, the need for culturally informed healthcare is critical and relevant,' says Heramed CEO Anoushka Gungadin.
News.com.au
3 hours ago
- News.com.au
Great gender divide playing out in kitchens across the country
It's the great gender divide playing out in kitchens across the country. When it comes to cooking dinner – the burden of preparing the nightly meal still overwhelmingly falls on women. The Dinner Heroes survey conducted by the Growth Intelligence Centre (GIC) found 72 per cent of women said they are solely responsible for cooking family dinners, compared with 49 per cent of men who said it fell on them. But it's Aussie dads who are rising to the occasion – with two in five saying they are solely responsible, and almost the same amount saying they share nightly cooking duties. And for Senior Lecturer in Public Health Dr Catherine Fleming, that is music to her ears. 'The family unity and the family dynamic are so important to having children learn to eat well and grow well,' Dr Fleming from Western Sydney University told 'There is so much evidence to show that that modelling (of children seeing their parents cooking) and especially coming from the dads is so important in helping a really healthy wellbeing environment within the home, which can contribute to lots of long-term health outcomes for these families that cook together, eat together, nourish together. 'For me, that's a fundamental part of learning and modelling those healthy skills,' Dr Fleming said. 'And young boys can see that 'hey Dad can cook really well, he is cooking great food that we can all eat and all share'. 'It doesn't just sit on the mum to then also choose a meal prep,' Dr Fleming said. 'I think it's a really important thing they get involved. If the dad's cooking he's probably planned what they're going to eat, shopped in the shops and got something on the way home. 'So seeing that whole process and understanding that process is really important for young girls and boys alike to see that dad's contributing and it's a family unit that's really sitting down to eat that meal. 'Food isn't just something that we eat that has no purpose in life. it plays a major role for all of us in the family,' she said. While an overwhelming number of Australians (85 per cent) agreed sharing meals is important, the survey found just over half eat at the dining table, while more than a quarter said the couch was where they ate dinner most often. One in five Gen Zers – those aged between 13 and 28 – who lived at home with their parents said they often ate their dinner in their bedrooms, with one in four living in four living in a share house said they did the same. Social researcher, author and Gen Z expert Dr Claire Madden said where families once gathered around the TV, technology now is so individualised. 'Gen Z is that one generation that has grown up on individualised devices and are accustomed to being in their own virtual world 24/7,' Dr Madden told 'It's the shift from when the TV was at the centre of the family home. 'But what we need to be aware of is that young people are craving connection and meaningful connection, and being on their devices is not satisfying deeper human connections,' Dr Madden said. Dr Madden said it was up to all of us to 'help shape the family culture' that we want, and can do this by encouraging putting away devices at meal times. 'What we need to consider is actually healthy disconnecting because these young people may not be aware of the process of what it took to make that meal,' she said. 'We can change these patterns in our households. We can say no devices during dinner. You can have it before and after dinner. 'You can take it in turns cooking and participating in the preparation … create an offline experience that is more fulfilling and engaging'. She said cooking and meal prepping are a great way to build connections between generations and give Gen Zers the deeper connections they crave. Dr Madden said young Australians like 'tactile, hands-on learning and cooking is an excellent way that produces results they can measure and see'. 'They can then take pictures of what they've cooked and share it online and on social media and show their achievement'. And when it came to time spent in the kitchen, the survey found one in four Aussies spent one to two hours cooking dinner each week, with a third (29 per cent) of Gen Z and Millennials admitting to spending between three and four hours a week cooking. The survey of 2083 Australians found Aussies have three or four go-to meals they cook each week, with one in five Gen Zers and Millennials more likely to cook something new for dinner two times a week, compared with 13 per cent of Gen Xers and 15 per cent of Boomers. The dinner experts at have teamed up with Coles to create 20 brand-new, flavour-packed Dinner Heroes recipes that are quick, simple and delicious. 'Some meals actually taste better the next day once the flavours mellow … think curries, stews, tomato-based sauces and soups,' Digital Food Director Amira Georgy told 'There are so many benefits to freezing meals, the biggest is that it saves you so much time and effort. On busy weeknights, having a ready-made meal to pull from the freezer is a godsend. It eliminates the need for last-minute cooking or resorting to expensive (and often less healthy) takeaway,' Ms Georgy said. One in four women and almost one in five men said they spent less than 15 minutes eating dinner, while unsurprisingly families with children under 12 said they spend between 30 and 45 minutes.
ABC News
5 hours ago
- ABC News
Regulators assessing bid to grow and sell genetically modified purple tomato in Australia
A genetically modified tomato the colour of an eggplant could be available on supermarket shelves as early as next year if regulators approved a bid to grow it in Australia. The purple tomato, as it is named, has been genetically modified to include genes from the edible snapdragon flower. Nathan Pumplin is the chief executive of Norfolk Healthy Produce, a United States-based company marketing the plant. He said the tomato had two snapdragon genes added, allowing it to make a class of antioxidants called anthocyanins, whose nutrients created the purple colour and were also associated with health benefits. "They're what make blueberries coloured, blackberries, eggplant skins, purple potatoes," Dr Pumplin said. The plant was developed by Cathie Martin at the John Innes Centre, an independent laboratory in the United Kingdom. She co-founded Norfolk Plant Sciences, a company aimed at transferring the fruits of the research to people's plates. Dr Pumplin said Professor Martin was a global leader in the study of how fruit and vegetables delivered nutrients to consumers. Professor Martin previously received the Rank Prize for Nutrition – one of the field's most prestigious awards – for her work. "She's also a type 1 diabetic, so her whole scientific career she's focused on ways to make the foods that we eat healthier and more nutritious," Dr Pumplin said. After 18 years of development the product was approved to be grown and sold in the US and has been on the market there for two years. Dr Pumplin said last year the company sold more than 100,000 punnets of the fruit at grocery stores and 13,000 packets of seeds to home gardeners. The team is now taking the plant worldwide and is focusing on the Australian and Canadian markets. All Aussie Farmers, a Victoria-based fresh produce marketing company, has entered an exclusive commercial partnership to bring the fruit here. Managing director Travis Murphy said there had already been plenty of interest. "Food service guys are wanting to know when they can get it for their chefs and our retail guys are asking when they can have it to put into their retail shops," he said. Australia has strict regulations on growing genetically modified crops and to date only canola, cotton, safflower, bananas and flowers have been approved. The Office of the Gene Technology Regulator (OGTR) is the government oversight body and crops will only be approved if they are proven to be safe for people and the environment. A spokesperson said a risk assessment of the purple tomato would be undertaken, which would lead to the development of a risk management plan to allow the plant to be grown and sold domestically. Public consultation will begin in September. "Written comments will be sought and the consultation will be open for at least 30 days," the OTGR spokesperson said. "Anyone can register to receive notifications on the OGTR website." All genetically modified foods for sale and consumption must also undergo a safety assessment by Food Standards Australia New Zealand. Mr Murphy said the purple tomato would first be grown in greenhouses in south-east Queensland, should approval be granted by early next year. "We'll roll it out to our customer base in Melbourne firstly, for the fruit shops and food service," he said. Distinguished Professor James Dale is familiar with the approvals process for genetically modified fruit. He leads the Queensland University of Technology's (QUT) Banana Biotechnology Research Program and has been able to get its genetically modified cavendish bananas approved. The banana is resistant to Panama Disease Tropical Race 4, which has threatened commercial production in northern Australia. Professor Dale said getting federal approval was difficult and required proof the fruit was safe for human consumption and the environment. "The application went to hundreds of pages of information because we had to document how we did all of those measurements," he said. The process took about 12 months, but Professor Dale said field trials in the Northern Territory had been completed. More trials will be conducted in north and south-east Queensland over the next three to four months before the crop will be grown commercially. "We're just going to make sure that the banana performs as well over in Queensland, because that's where the vast majority of bananas are grown in Australia," Professor Dale said. The disease-resistant variety is a standard yellow colour, but Professor Dale said the team was working to make bananas healthier and was developing an orange banana high in provitamin A and another high in iron. He said a purple banana with high levels of anthocyanins was also possible. "The purple patches that you see on banana leaves are actually anthocyanins," Professor Dale said.
